Mars 2 Mesothelioma Trial, Mesothelioma Clinical Trials Study Highlights Challenges For Patients

You have these drugs through a drip into a vein once every 3 weeks.

Cute pictures to color and print. It is a difficult study but we did not choose surgery because it is an easy life. The study will test the hypothesis that surgery and chemotherapy is superior to chemotherapy alone with respect to overall. National institute for health research health technology assessment programme.

A multicentre randomised trial comparing extended pleurectomy decortication versus no extended pleurectomy decortication for patients with malignant pleural mesothelioma mars 2 funder acknowledgement. The mars mesothelioma and radical surgery trial is recruiting in the uk with the intention that if its implementation proves feasible it will become an international trial. Malignant pleural mesothelioma is now a common disease particularly in britain but the role of radical surgery had never been examined in a randomised trial.

Warnock c lord k taylor b tod a. Mars was a multicentre randomised controlled trial in 12 uk hospitals. This trial has provided a unique opportunity to conduct an embedded qualitative evaluation to generate insights into the patient experience of.

Findings from the mesothelioma and radical surgery trial 2 mars 2. Lung cancer other cancers treatment modality. This is a phase 3 trialthe researchers need 328 people to join.

Challenges have been reported in conducting clinical research into thoracic surgical treatments and evidence is required to improve our understanding of patient experiences. Each 3 week period is called a cycle of treatment and you have 2 cycles. Several phase 2 studies have been reported on the role of neoadjuvant chemotherapy epp and postoperative radiotherapy.

You would have this chemotherapy whether you took part in this trial or not. Mesothelioma and radical surgery trial mars disease site. The value of extrapleural pneumonectomy epp in the context of multimodality therapy for patients with malignant pleural mesothelioma is controversial.

Mesothelioma and radical surgery 2. This is a serious question that we have to answer. The pilot study for mars 2 evaluated the viability of recruitment.

Patient experiences of participation in a radical thoracic surgical trial. First of all everyone taking part has chemotherapy for mesotheliomayour doctor will decide which drugs you have. Patients aged 18 years or older who had pathologically confirmed mesothelioma and were deemed fit enough to undergo trimodal therapy were included.

The mesothelioma and radical surgery trial mars 2 aims to evaluate a surgical procedure by comparing chemotherapy and surgery against chemotherapy alone.